Literature DB >> 20894635

Cancer research - the lessons from Hodgkin's disease.

T G Allen-Mersh1.   

Abstract

Entities:  

Year:  1986        PMID： 20894635      PMCID： PMC1290524          DOI： 10.1177/014107688607901103

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  10 in total

1.  Non-Hodgkin's lymphomas. IV. Clinicopathologic correlation in 405 cases.

Authors:  S E Jones; Z Fuks; M Bull; M E Kadin; R F Dorfman; H S Kaplan; S A Rosenberg; H Kim
Journal:  Cancer       Date:  1973-04       Impact factor: 6.860

Review 2.  Epidermoid cancer of the anus.

Authors:  M J Greenall; S H Quan; J J DeCosse
Journal:  Br J Surg       Date:  1985-09       Impact factor: 6.939

3.  Clinical research in universities.

Authors: 
Journal:  Lancet       Date:  1986-04-05       Impact factor: 79.321

4.  The Stoker Report and the future of Northwick Park.

Authors:  C C Booth
Journal:  Lancet       Date:  1986-02-15       Impact factor: 79.321

Review 5.  Adjuvant systemic therapy for resectable breast cancer.

Authors:  G Bonadonna; P Valagussa
Journal:  J Clin Oncol       Date:  1985-02       Impact factor: 44.544

6.  Evidence for a tumoricidal dose level in the radiotherapy of Hodgkin's disease.

Authors:  H S Kaplan
Journal:  Cancer Res       Date:  1966-06       Impact factor: 12.701

7.  Evidence for an orderly progression in the spread of Hodgkin's disease.

Authors:  S A Rosenberg; H S Kaplan
Journal:  Cancer Res       Date:  1966-06       Impact factor: 12.701

8.  Cisplatin, vindesine, and bleomycin chemotherapy of local-regional and advanced esophageal carcinoma.

Authors:  D Kelsen; B Hilaris; C Coonley; R Chapman; M Lesser; M Dukeman; R Heelan; M Bains
Journal:  Am J Med       Date:  1983-10       Impact factor: 4.965

9.  Advanced ovarian cancer: brief intensive combination chemotherapy and second-look operation.

Authors:  F A Greco; C G Julian; R L Richardson; L Burnett; K R Hande; R K Oldham
Journal:  Obstet Gynecol       Date:  1981-08       Impact factor: 7.661

10.  Prospective randomized evaluation of adjuvant chemotherapy in adults with soft tissue sarcomas of the extremities.

Authors:  S A Rosenberg; J Tepper; E Glatstein; J Costa; R Young; A Baker; M F Brennan; E V Demoss; C Seipp; W F Sindelar; P Sugarbaker; R Wesley
Journal:  Cancer       Date:  1983-08-01       Impact factor: 6.860
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.